Unique ID issued by UMIN | UMIN000036098 |
---|---|
Receipt number | R000041123 |
Scientific Title | The effect of lowering blood glucose regarding SGLT2 inhibitor in type 1 diabetes mellitus |
Date of disclosure of the study information | 2019/03/06 |
Last modified on | 2020/09/05 11:37:56 |
The effect of lowering blood glucose regarding SGLT2 inhibitor in type 1 diabetes mellitus
The effect of SGLT2 inhibitor in type 1 diabetes mellitus
The effect of lowering blood glucose regarding SGLT2 inhibitor in type 1 diabetes mellitus
The effect of SGLT2 inhibitor in type 1 diabetes mellitus
Japan |
Type 1 diabetes mellitus
Endocrinology and Metabolism |
Others
NO
Comparison of improving blood glucose and glucose variability between SGLT2 inhibitor and alpha
glucosidase inhibitor
Safety,Efficacy
HbA1c, Total daily dose of insulin, BMI
average blood glucose, standard deviation, mean amplitude of glycemic excursion
Interventional
Cross-over
Randomized
Individual
Open -no one is blinded
Active
2
Treatment
Medicine |
Administrating Ipragliflozin 50 mg/day on basal-bolus insulin for 12 weeks
Administrating Voglibose 0.9 mg/day on basal-bolus insulin for 12 weeks
18 | years-old | <= |
75 | years-old | > |
Male and Female
Type 1 diabetic patients who treat only basal-bolus therapy
1.Patients who treat with CSII.
2.Patients who have history of diabetic coma, severe diabetic ketosis or hyperglycemic hyperosmolar symdrome.
3.1. Patients with severe infection, severe injury or perioperative state.
4.1. Patients with severe diabetic complications such as neuropathy, retinopathy and nephropathy.
5.BMI of patients under 17.5 kg/m2.
6.eGFR of patients less than 45 mL/min/1.73m2.
7.Patients with history of ileus.
8.Patients with vulvitis.
9.Pregnant
10.Patients whom researchers rule out as inappropriate subjects.
20
1st name | Hiroaki Yagyu |
Middle name | |
Last name | Hiroaki Yagyu |
Tsukuba University Hospital Mito Clinical Education and Training Center Mito Kyodo General Hospital
Endocrinology and Metabolism
310-0015
3-2-7 Miya-machi, Mito, Ibaraki, Japan 310-0015
029-231-2371
hiroakiyagyu@md.tsukuba.ac.jp
1st name | Ryo Kumagai |
Middle name | |
Last name | Ryo Kumagai |
Tsukuba University Hospital Mito Clinical Education and Training Center Mito Kyodo General Hospital
Endocrinology and Metabolism
310-0015
3-2-7 Miya-machi, Mito, Ibaraki, Japan 310-0015
029-231-2371
kumaryo1818@gmail.com
Tsukuba University Hospital Mito Clinical Education and Training Center Mito Kyodo General Hospital
Tsukuba University Hospital Mito Clinical Education and Training Center Mito Kyodo General Hospital
Self funding
Tsukuba University Hospital Mito Clinical Education and Training Center Mito Kyodo General Hospital
3-2-7 Miya-machi, Mito, Ibaraki, Japan 310-0015
029-231-2371
kumaryo1818@gmail.com
NO
2019 | Year | 03 | Month | 06 | Day |
Unpublished
Suspended
2019 | Year | 02 | Month | 12 | Day |
2019 | Year | 03 | Month | 01 | Day |
2019 | Year | 03 | Month | 06 | Day |
2020 | Year | 06 | Month | 30 | Day |
2020 | Year | 10 | Month | 10 | Day |
2020 | Year | 10 | Month | 10 | Day |
2020 | Year | 10 | Month | 10 | Day |
2019 | Year | 03 | Month | 06 | Day |
2020 | Year | 09 | Month | 05 | Day |
Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000041123
Research Plan | |
---|---|
Registered date | File name |
Research case data specifications | |
---|---|
Registered date | File name |
Research case data | |
---|---|
Registered date | File name |